Kunal Kanani

Kunal Kanani has extensive experience in regulatory affairs within the pharmaceutical industry. Kunal is currently serving as the Head of Regulatory Affairs at Annexon Biosciences since July 2022. Prior to this, they worked at Zogenix, Inc. where they held the positions of Senior Director of Global Regulatory Affairs from December 2020 to July 2022, and Director of Global Regulatory Affairs from December 2018 to December 2020. Kunal also has previous experience at Ultragenyx Pharmaceutical Inc., where they worked as an Associate Director of Regulatory Affairs from August 2017 to December 2018, and as a Senior Manager of Regulatory Affairs from May 2016 to August 2017. Before joining Ultragenyx, they worked at Noven Pharmaceuticals as an Associate Director of Regulatory Affairs from January 2016 to May 2016, as a Senior Manager of Regulatory Affairs from April 2015 to December 2015, and as a Manager of Regulatory Affairs from May 2014 to April 2015. Additionally, they have worked as a Per Diem Pharmacist at Novecks Pharmacy, Target Pharmacy from July 2012 to May 2016. Kunal Kanani started their career as a Medical Affairs/Clinical Operations Post Doctoral Fellow at Bayer HealthCare from July 2012 to June 2014. Kunal also served as an Adjunct Faculty at Rutgers School of Pharmacy from July 2012 to June 2014. Prior to that, they worked as a Chemical Analyst at Impax Laboratories from January 2008 to July 2008.

Kunal Kanani completed their Doctor of Pharmacy (Pharm.D.) degree from Lake Erie College of Osteopathic Medicine, attending from 2008 to 2012. Prior to that, they studied at The University of Georgia from 2003 to 2007 and earned a Bachelor of Science (B.S.) degree in Chemistry. Currently, Kunal is pursuing a Master of Business Administration (MBA) degree at Boston University, starting in 2021 and expected to finish in 2023. The field of study for their MBA degree is not specified.